Ionis treatment for Alexander disease granted orphan drug status from EMA
- Tuesday, February 11, 2020, 7:12
- Business
- Add a comment
CARLSBAD, Calif., Feb. 11, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that the European Medicines Agency (EMA) has granted orphan drug designation to ION373 for the treatment of people with Alexander disease, a…
About the Author
adminasapcorp has written 41769 stories on this site.